Search results for "Prolongation"

showing 8 items of 8 documents

Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

2016

Aims: The objective of this study was to evaluate the prevalence of the prescription of QT-prolonging drugs at hospital admission and discharge and the risk factors associated with their use in older people (aged 65 years and older). Methods: Data were obtained from the REPOSI (REgistro POliterapie SIMI [Società Italiana di Medicina Interna]) registry, which enrolled 4035 patients in 2008 (n = 1332), 2010 (n = 1380), and 2012 (n = 1323). Multivariable logistic regression was performed to determine the risk factors independently associated with QT-prolonging drug use. QT-prolonging drugs were classified by the risk of Torsades de Pointes (TdP) (definite, possible, or conditional) acc…

MaleTORSADES-DE-POINTES INTERVAL PROLONGATION PATIENT CIPROFLOXACIN COHORT DEATH MULTIMORBIDITY AMIODARONE MORTALITY AIFA.Amiodarone030204 cardiovascular system & hematologyCIPROFLOXACINLogistic regressionAmiodaroneElectrocardiography0302 clinical medicineRisk FactorsTorsades de PointesAtrial Fibrillation80 and overPrevalencePharmacology (medical)030212 general & internal medicineAged; Aged 80 and over; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Discharge; Prevalence; Risk Factors; Torsades de Pointes; Hospitalizationmedia_commonAged 80 and overTorsades de PointeAged; Aged 80 and over; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Discharge; Prevalence; Risk Factors; Torsades de Pointes; Hospitalization; Pharmacology (medical); Geriatrics and Gerontology; Medicine (all)Medicine (all)DEATHMiddle AgedPatient DischargeHospitalizationLong QT SyndromeCohortHospitalized Older PeopleFemalemedicine.drugHumanDrugmedicine.medical_specialtymedia_common.quotation_subjectMULTIMORBIDITYTorsades de pointesPATIENT03 medical and health sciencesPharmacotherapyInternal medicineINTERVAL PROLONGATIONmedicineHumansTORSADES-DE-POINTESCOHORTMedical prescriptionAIFAAgedbusiness.industryMORTALITYRisk FactorSettore MED/09 - MEDICINA INTERNAOdds ratiomedicine.diseaseQT-Prolonging DrugAged; Aged 80 and over; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Discharge; Prevalence; Risk Factors; Torsades de Pointes; Hospitalization; Geriatrics and Gerontology; Pharmacology (medical)Physical therapyGeriatrics and Gerontologybusiness
researchProduct

Changes of QTc interval after opioid switching to oral methadone.

2013

Abstract A consecutive sample of patients who were switched from strong opioids to methadone in a period of 1 year was surveyed. QTc was assessed before switching (T0) and after achieving adequate analgesia and an acceptable level of adverse effects (Ts). Twenty-eight of 33 patients were switched to methadone successfully. The mean initial methadone doses at T0 were 67.1 mg/day (SD ±80.2, range 12-390). The mean QTc interval at T0 was 400 ms (SD ±30, range 330-450). The mean QTc interval at Ts (median 5 days) was 430 ms (SD ±26, range 390-500). The difference (7.7 %) was significant (p < 0.0005). Only two patients had a QTc of 500 ms. No serious arrhythmia was observed. At the linear regres…

MaleRiskCancer pain; Methadone; QT prolongation; Toxicity; Opioid switchingPainSettore MED/41 - AnestesiologiaQT prolongationSettore MED/42 - Igiene Generale E ApplicataQT intervalCONSECUTIVE SAMPLEElectrocardiographyNeoplasmsOpiate Substitution TreatmentmedicineHumansIn patientcardiovascular diseasesCancer painAdverse effectAgedToxicitybusiness.industryMiddle AgedAnalgesics OpioidLong QT SyndromeOncologyOpioidAnesthesiaToxicityLinear Modelscardiovascular systemOpioid switchingFemaleCancer painbusinessMethadoneMethadonemedicine.drug
researchProduct

A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematolog…

2006

Abstract Purpose: LBH589 is a novel histone deacetylase inhibitor that inhibits proliferation and induces apoptosis in tumor cell lines. In this phase I study, LBH589 was administered i.v. as a 30-minute infusion on days 1 to 7 of a 21-day cycle. Experimental Design: Fifteen patients (median age, 63 years; range, 42-87 years) with acute myeloid leukemia (13 patients), acute lymphocytic leukemia (1 patient), or myelodysplastic syndrome (1 patient) were treated with LBH589 at the following dose levels (mg/m2): 4.8 (3 patients), 7.2 (3 patients), 9.0 (1 patient), 11.5 (3 patient), and 14.0 (5 patients). The levels of histone acetylation were measured using quantitative flow cytometry and plasm…

AdultCancer ResearchIndolesMaximum Tolerated Dosemedicine.drug_classApoptosisPharmacologyHydroxamic AcidsDrug Administration ScheduleHistonesStructure-Activity Relationshipchemistry.chemical_compoundPredictive Value of TestsPanobinostatAcute lymphocytic leukemiaPanobinostatBiomarkers TumormedicineHumansEnzyme InhibitorsAgedCell ProliferationAged 80 and overDose-Response Relationship Drugbusiness.industryHistone deacetylase inhibitorArea under the curveQTcF ProlongationMyeloid leukemiaMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseHypokalemiaHistone Deacetylase InhibitorsLeukemiaTreatment OutcomeOncologychemistryCinnamatesLeukemia MyeloidMyelodysplastic SyndromesAcute DiseaseInjections IntravenousImmunologymedicine.symptombusinessFollow-Up StudiesClinical Cancer Research
researchProduct

Suppression of Electrographic Seizures Is Associated with Amelioration of QTc Interval Prolongation in Patients with Traumatic Brain Injury.

2021

Introduction: Disorders in electroencephalography (EEG) are commonly noted in patients with traumatic brain injury (TBI) and may be associated with electrocardiographic disturbances. Electrographic seizures (ESz) are the most common features in these patients. This study aimed to explore the relationship between ESz and possible changes in QTc interval and spatial QRS-T angle both during ESz and after ESz resolution. Methods: Adult patients with TBI were studied. Surface 12-lead ECGs were recorded using a Cardiax device during ESz events and 15 min after their effective suppression using barbiturate infusion. The ESz events were diagnosed using Masimo Root or bispectral index (BIS) devices.…

medicine.medical_specialtyTraumatic brain injurymedicine.drug_classseizureQTc intervalElectroencephalographyQT intervalArticlebrain–heart interactionInternal medicinemedicineIn patientcardiovascular diseasesCerebral oximetrymedicine.diagnostic_testbusiness.industryspatial QTS-T angletraumatic brain injuryRGeneral Medicinemedicine.diseaseBarbiturateBispectral indexQtc interval prolongationCardiologyMedicinebusinessJournal of clinical medicine
researchProduct

Extremal polynomials in stratified groups

2018

We introduce a family of extremal polynomials associated with the prolongation of a stratified nilpotent Lie algebra. These polynomials are related to a new algebraic characterization of abnormal subriemannian geodesics in stratified nilpotent Lie groups. They satisfy a set of remarkable structure relations that are used to integrate the adjoint equations.

Statistics and Probabilityextremal polynomialsMathematics - Differential GeometryPure mathematicsGeodesicStructure (category theory)Group Theory (math.GR)Characterization (mathematics)algebra01 natural sciencesdifferentiaaligeometriaMathematics - Analysis of PDEsMathematics - Metric Geometry53C17FOS: Mathematics0101 mathematicsAlgebraic numberMathematics - Differential Geometry; Mathematics - Differential Geometry; Mathematics - Analysis of PDEs; Mathematics - Group Theory; Mathematics - Metric Geometry; Mathematics - Optimization and Control; 53C17; 49K30; 17B70Mathematics - Optimization and ControlMathematics010102 general mathematicsStatisticsta111polynomitProlongation53C17 49K30 17B70Lie groupMetric Geometry (math.MG)abnormal extremals010101 applied mathematicsNilpotent Lie algebraNilpotentsub-Riemannian geometryabnormal extremals extremal polynomials Carnot groups sub-Riemannian geometryAbnormal extremals; Carnot groups; Extremal polynomials; Sub-Riemannian geometry; Analysis; Statistics and Probability; Geometry and Topology; Statistics Probability and UncertaintyDifferential Geometry (math.DG)Optimization and Control (math.OC)Carnot groups17B70Probability and UncertaintyGeometry and TopologyStatistics Probability and UncertaintyMathematics - Group TheoryAnalysisAnalysis of PDEs (math.AP)Mathematics - Differential Geometry; Mathematics - Differential Geometry; Mathematics - Analysis of PDEs; Mathematics - Group Theory; Mathematics - Metric Geometry; Mathematics - Optimization and Control; 53C17 49K30 17B7049K30
researchProduct

Prolongation de la vie et vieillissement (XVIe-XVIIIe siècle)

2010

International audience

[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/LawvieillissementXVIe-XVIIIe sièclesprolongation de la vie[ SHS.DROIT ] Humanities and Social Sciences/LawComputingMilieux_MISCELLANEOUS
researchProduct

La fin du contrat de travail à durée déterminée dit d'usage dans le sport professionnel

2023

(Soc., 21 sept. 2022, no 21-12.590, publié au Bulletin)

Action en requalification[SHS.DROIT] Humanities and Social Sciences/LawContrat de TravailProlongation du CDDCDDSportif professionnel
researchProduct

Overdose of Quetiapine—A Case Report with QT Prolongation

2021

Quetiapine is an atypical antipsychotic drug used to treat bipolar disorder, schizophrenia, and major depressive disorder. Although several studies describe the adverse effects of intoxication with Quetiapine, only a few report an extreme overdose without comedications that lead to a life threat. We present a case of a 75-year-old male who tried to attempt suicide by ingesting 28 g of Quetiapine. During the management in the emergency department, both serum and urine samples were collected, allowing a complete pharmacokinetic analysis to be conducted, from the admission to the discharge.

Chemical Health and SafetySettore MED/43 - Medicina LegaleintoxicationChemical technologyHealth Toxicology and MutagenesisSettore BIO/14 - FarmacologiaCase ReportTP1-1185quetiapineToxicologySettore MED/25 - PsichiatriaIntoxication; QT-prolongation; QuetiapineQT-prolongationToxics
researchProduct